Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size.

Parish, C L; Stanic, D; Drago, J; Borrelli, E; Finkelstein, D I; Horne, M K

Parish, C L; Stanic, D; Drago, J; Borrelli, E; Finkelstein, D I; Horne, M K.

Affiliation

Parish CL; Neurosciences Group, Department of Medicine, Monash University, Monash Medical Centre, 246 Clayton Road, Clayton 3168, Australia.

Eur J Neurosci ; 16(5): 787-94, 2002 Sep.

Article in En | MEDLINE | ID: mdl-12372014

Subject(s)

Axons/drug effects; Dopamine Agonists/pharmacology; Dopamine Antagonists/pharmacology; Dopamine D2 Receptor Antagonists; Membrane Glycoproteins; Nerve Tissue Proteins; Receptors, Dopamine D2/agonists; Substantia Nigra/anatomy & histology; Substantia Nigra/cytology; Animals; Cocaine/adverse effects; Dopamine; Dopamine Plasma Membrane Transport Proteins; Immunohistochemistry; Male; Membrane Transport Proteins/analysis; Mice; Mice, Knockout; Rats; Rats, Wistar; Receptors, Dopamine D1/agonists; Receptors, Dopamine D1/antagonists & inhibitors; Receptors, Dopamine D2/genetics

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Axons / Substantia Nigra / Membrane Glycoproteins / Receptors, Dopamine D2 / Dopamine Antagonists / Dopamine Agonists / Dopamine D2 Receptor Antagonists / Nerve Tissue Proteins Limits: Animals Language: En Year: 2002 Type: Article

Search on Google

XML

PubMed Links